Primary Site >> Colorectal Cancer

Gene >> MST1R

Journal: Int J Cancer. 1999 Nov 26;83(5):579-84.
Title: Comparative tyrosine-kinase profiles in colorectal cancers: enhanced arg expression in carcinoma as compared with adenoma and normal mucosa.
Author: Chen, W S|Kung, H J|Yang, W K|Lin, W c
PMID: 10521789
Journal: Int J Oncol. 1999 Oct;15(4):709-14.
Title: Presence of RON receptor tyrosine kinase and its splicing variant in malignant and non-malignant human colonic mucosa.
Author: Okino, T|Egami, H|Ohmachi, H|Takai, E|Tamori, Y|Nakagawa, K|Nakano, S|Akagi, J|Sakamoto, O|Suda, T|Ogawa, M
PMID: 10493952
Journal: Carcinogenesis. 2000 Aug;21(8):1507-12.
Title: Identification of a novel splicing product of the RON receptor tyrosine kinase in human colorectal carcinoma cells.
Author: Wang, M H|Kurtz, A L|Chen, Y
PMID: 10910951
Journal: Exp Cell Res. 2000 Nov 25;261(1):229-38.
Title: Overexpression and activation of the RON receptor tyrosine kinase in a panel of human colorectal carcinoma cell lines.
Author: Chen, Y Q|Zhou, Y Q|Angeloni, D|Kurtz, A L|Qiang, X Z|Wang, M H
PMID: 11082293
Journal: Mol Cell. 2005 Dec 22;20(6):881-90.
Title: Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene.
Author: Ghigna, Claudia|Giordano, Silvia|Shen, Haihong|Benvenuto, Federica|Castiglioni, Fabio|Comoglio, Paolo Maria|Green, Michael R|Riva, Silvano|Biamonti, Giuseppe
PMID: 16364913
Journal: Cancer Biol Ther. 2007 Jul;6(7):1121-9.
Title: Blocking tumorigenic activities of colorectal cancer cells by a splicing RON receptor variant defective in the tyrosine kinase domain.
Author: Wang, Ming-Hai|Lao, Wei-Feng|Wang, Da|Luo, Yu Lan|Yao, Hang-Ping
PMID: 17611409
Journal: J Biol Chem. 2008 Dec 12;283(50):35295-304.
Title: Unbiased screening for transcriptional targets of ZKSCAN3 identifies integrin beta 4 and vascular endothelial growth factor as downstream targets.
Author: Yang, Lin|Zhang, Li|Wu, Qiuyu|Boyd, Douglas D
PMID: 18940803
Journal: Mol Carcinog. 2009 Nov;48(11):995-1004.
Title: The Ron receptor tyrosine kinase is not required for adenoma formation in Apc(Min/+) mice.
Author: Meyer, Sara E|Waltz, Susan E|Goss, Kathleen H
PMID: 19452510
Journal: Int J Oncol. 2010 Aug;37(2):473-82.
Title: Monoclonal antibody (mAb)-induced down-regulation of RON receptor tyrosine kinase diminishes tumorigenic activities of colon cancer cells.
Author: Li, Zhuzhu|Yao, Hangping|Guin, Sunny|Padhye, Snehal S|Zhou, Yong-Qing|Wang, Ming-Hai
PMID: 20596675
Journal: Cancer Chemother Pharmacol. 2011 May;67(5):1073-83.
Title: Targeting acute hypoxic cancer cells by doxorubicin-immunoliposomes directed by monoclonal antibodies specific to RON receptor tyrosine kinase.
Author: Guin, Sunny|Ma, Qi|Padhye, Snehal|Zhou, Yong-Qing|Yao, Hang-Ping|Wang, Ming-Hai
PMID: 20658288
Journal: Mol Cancer. 2011 Jul 12;10:82.
Title: The monoclonal antibody Zt/f2 targeting RON receptor tyrosine kinase as potential therapeutics against tumor growth-mediated by colon cancer cells.
Author: Yao, Hang-Ping|Zhou, Yong-Qing|Ma, Qi|Guin, Sunny|Padhye, Snehal S|Zhang, Rui-Wen|Wang, Ming-Hai
PMID: 21749705
Journal: Invest New Drugs. 2012 Apr;30(2):518-23.
Title: Evaluation of a multi-kinase inhibitor KRC-108 as an anti-tumor agent in vitro and in vivo.
Author: Han, Sun-Young|Lee, Chong Ock|Ahn, Sung-Hoon|Lee, Mi-Ok|Kang, So-Young|Cha, Hyuk-Jin|Cho, Sung Yun|Ha, Jae Du|Ryu, Jae Wook|Jung, Heejung|Kim, Hyoung Rae|Koh, Jong Sung|Lee, Jongkook
PMID: 21080208
Journal: Exp Cell Res. 2012 Dec 10;318(20):2548-58.
Title: A novel variant of the RON receptor tyrosine kinase derived from colorectal carcinoma cells which lacks tyrosine phosphorylation but induces cell migration.
Author: Wang, Da|Lao, Wei-Feng|Kuang, Ye-Ye|Geng, Shu-Min|Mo, Li-Juan|He, Chao
PMID: 22975341
Journal: Oncol Rep. 2012 Dec;28(6):2217-20.
Title: Identification of novel splicing variants from RON proto-oncogene pre-mRNA.
Author: Moon, Heegyum|Cho, Sunghee|Yang, Xiaoming|Zhou, Jianhua|Loh, Tiing Jen|Zheng, Xuexiu|Shen, Haihong
PMID: 22993024
Journal: Clin Cancer Res. 2014 Dec 1;20(23):6045-58.
Title: Efficacy of anti-RON antibody Zt/g4-drug maytansinoid conjugation (Anti-RON ADC) as a novel therapeutics for targeted colorectal cancer therapy.
Author: Feng, Liang|Yao, Hang-Ping|Wang, Wei|Zhou, Yong-Qing|Zhou, Jianwei|Zhang, Ruiwen|Wang, Ming-Hai
PMID: 25294907
Journal: Proc Natl Acad Sci U S A. 2017 Apr 4;114(14):E2852-E2861.
Title: Three-dimensional culture system identifies a new mode of cetuximab resistance and disease-relevant genes in colorectal cancer.
Author: Li, Cunxi|Singh, Bhuminder|Graves-Deal, Ramona|Ma, Haiting|Starchenko, Alina|Fry, William H|Lu, Yuanyuan|Wang, Yang|Bogatcheva, Galina|Khan, Mohseen P|Milne, Ginger L|Zhao, Shilin|Ayers, Gregory Daniel|Li, Nenggan|Hu, Huaying|Washington, Mary Kay|Yeatman,
PMID: 28320945
Journal: Exp Ther Med. 2017 Jul;14(1):338-343.
Title: Next-generation sequencing reveals lymph node metastasis associated genetic markers in colorectal cancer.
Author: Xie, Ni|Yao, Yujiang|Wan, Lili|Zhu, Ting|Liu, Litao|Yuan, Jianhui
PMID: 28672935